Biocon Biologics gets complete response letter from USFDA for Biosimilar Insulin Aspart

The company had submitted a comprehensive Corrective and Preventive Action (CAPA) plan in September 2022

Moberg Pharma has completed enrollment to the Phase 3 study for MOB-015 in North America

Thermo Fisher Scientific expands St. Louis manufacturing for complex biologic treatments

Increased capability to produce medicines for challenging diseases including cancer

Cambrex completes US$38 million capacity expansion in High Point, North Carolina

Amgen completes acquisition of Horizon Therapeutics

Advances Amgen's mission to serve patients with rare disease medicines

Ministry of Ayush to launch special campaign 3.0,

The Main campaign started from October 2

Aurobindo Pharma completes sale of Antibiotic business to Apitoria Pharma

The sale/transfer of the Company's API NonAntibiotic Business and API Antibiotic Business to Apitoria are complete

AstraZeneca Pharma India gets permission to import Palivizumab solution for injection

Palivizumab (Synagis) is indicated for the prevention of serious lower respiratory tract disease requiring hospitalization caused by respiratory syncytial virus

Advent International announces the completion of the acquision of Suven Pharma

New Board of Directors and management team at Suven Pharma also appointed

27,353 hospitals empanelled under PM-JAY

30 beneficiaries avail of services per minute